The Washington Post - Once in Limbo, Promising Duchenne Muscular Dystrophy Drug Back on Track Toward Approval

April 20, 2014

Eric Hoffman, Ph.D., chair and professor of integrative systems biology, was quoted in The Washington Post for an article on FDA review of a drug that may slow the progression of­­ ­Duchenne muscular dystrophy.